Leber; Andrew
Patent Applications and Registrations
Patent applications and USPTO patent grants for Leber; Andrew.The latest application filed is for "lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same".
- Leber; Andrew - Blacksburg VA
| Patent | Date |
|---|---|
| Lanthionine C-like Protein 2 Ligands, Cells Prepared Therewith, And Therapies Using Same App 20220274950 - Bassaganya-Riera; Josep ; et al. | 2022-09-01 |
| Lanthionine C-like protein 2 ligands, cells prepared therewith, and therapies using same Grant 11,377,437 - Bassaganya-Riera , et al. July 5, 2 | 2022-07-05 |
| Compounds, Compositions, And Methods For Treating Inflammatory Or Immune-mediated Conditions Of Surface Tissues App 20220152019 - Bassaganya-Riera; Josep ; et al. | 2022-05-19 |
| Crystalline Forms Of Piperazine-1,4-diylbis((6-(1h-benzo[d]imidazo-2-yl)pyridin-2yl)methanone) App 20220135541 - Bassaganya-Riera; Josep ; et al. | 2022-05-05 |
| Lancl Ligands App 20220127250 - Bassaganya-Riera; Josep ; et al. | 2022-04-28 |
| Nlrx1 Ligands App 20220089586 - Bassaganya-Riera; Josep ; et al. | 2022-03-24 |
| Therapies With Lanthionine C-like Protein 2 Ligands And Cells Prepared Therewith App 20220072044 - Bassaganya-Riera; Josep ; et al. | 2022-03-10 |
| Plxdc2 Ligands App 20220017488 - Bassaganya-Riera; Josep ; et al. | 2022-01-20 |
| Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith Grant 11,197,891 - Bassaganya-Riera , et al. December 14, 2 | 2021-12-14 |
| PLXDC2 ligands Grant 11,180,473 - Bassaganya-Riera , et al. November 23, 2 | 2021-11-23 |
| Lanthionine C-like Protein 2 Ligands, Cells Prepared Therewith, And Therapies Using Same App 20210355101 - Bassaganya-Riera; Josep ; et al. | 2021-11-18 |
| Nlrx1 Ligands App 20210309610 - Bassaganya-Riera; Josep ; et al. | 2021-10-07 |
| Plxdc2 Ligands App 20210309635 - Bassaganya-Riera; Josep ; et al. | 2021-10-07 |
| Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same Grant 11,117,881 - Bassaganya-Riera , et al. September 14, 2 | 2021-09-14 |
| NLRX1 ligands Grant 11,066,364 - Bassaganya-Riera , et al. July 20, 2 | 2021-07-20 |
| Lanthionine C-like Protein 2 Ligands, Cells Prepared Therewith, And Therapies Using Same App 20210188800 - Bassaganya-Riera; Josep ; et al. | 2021-06-24 |
| Nlrx1 Ligands App 20200255378 - Kind Code | 2020-08-13 |
| NLRX1 ligands Grant 10,676,436 - Bassaganya-Riera , et al. | 2020-06-09 |
| Nlrx1 Ligands App 20200010417 - Bassaganya-Riera; Josep ; et al. | 2020-01-09 |
| NLRX1 ligands Grant 10,487,057 - Bassaganya-Riera , et al. Nov | 2019-11-26 |
| Therapies With Lanthionine C-like Protein 2 Ligands And Cells Prepared Therewith App 20190160100 - Bassaganya-Riera; Josep ; et al. | 2019-05-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 